Search Results 1131-1140 of 17070 for Vaginal suppositories

  1. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  2. Methylphenidate (oral route) - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release, ...

  3. Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo - Mayo Clinic

    Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid ( ...

  4. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

  5. Joel Streed | Mayo Clinic News Network - Page 79 of 170

    Gynecologic cancers are cancers that start in a woman's reproductive organs. The five main types are: cervical, endometrial, ovarian, vaginal and vulvar ...

  6. A Study To Evaluate Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications For The Treatment Of Heart Failure (DIAMOND) - Mayo Clinic

    A Study To Evaluate Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications For ...

  7. Mayo Clinic

    cc-nose-spray_thumbnail ; About Mayo Clinic · About this Site · Contact Us ; Medical · AskMayoExpert · Clinical Trials ; Businesses · Executive Health Program.

  8. A Study To Evaluate The Effectiveness And Safety Of Vibegron Administered Orally For 12 Weeks To Women With Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  9. Bupivacaine (implantation route) - Side effects & uses - Mayo Clinic

    Bupivacaine implant is used to prevent pain for up to 24 hours after surgery in the groin area (open inguinal hernia repair). It is a local anesthetic.

  10. ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - Mayo Clinic

    About this study. This is a randomised, open label multi-centre phase III study comparing the activity of lapatinib alone versus trastuzumab alone versus ...